Inactive Instrument

AXIOGENES Share Price

Equities

AI8

DE0006048267

Biotechnology & Medical Research

End-of-day quote Xetra Other stock markets
- ^EUR	-

Press releases AXIOGENES

Axiogenes : s : Signs Sublicensing Agreement for Cellular Assay Patents with GE Healthcare.	14/07/15	BU
AXIOGENES : Axiogenesis Earns U.S. Patent with In Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy	04/12/12	BU
AXIOGENES : At Last, a Cardiomyopathy Disease Model: Axiogenesis Has Been Granted a Far-Reaching Patent in Europe	10/10/11	BU

More press releases

News in other languages on AXIOGENES

Axiogenes : s : und GE Healthcare unterzeichnen Sub-Lizenzvertrag über Patente für zelluläre Testsysteme

16/07/15

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
LONZA GROUP AG	+38.65%	39.1B
IQVIA HOLDINGS INC.	-8.62%	38.76B
ALNYLAM PHARMACEUTICALS, INC.	+26.95%	31.24B
ICON PUBLIC LIMITED COMPANY	+10.74%	25.9B
CELLTRION, INC.	-13.50%	25.8B
UNITED THERAPEUTICS CORPORATION	+44.87%	14.06B
MEDPACE HOLDINGS, INC.	+34.36%	13.12B
BIO-TECHNE CORPORATION	-7.14%	11.32B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-12.61%	10.68B

Other Biotechnology & Medical Research

Protect and grow your investments with the help of our experts

Securing my Investments

fermer